HK1193612A1 - 用於製備 -甲基- -四氫- -苯並吖庚因- -基羰基 苄基氨基甲醯基- -脯氨酸- -二甲基醯胺的方法 - Google Patents

用於製備 -甲基- -四氫- -苯並吖庚因- -基羰基 苄基氨基甲醯基- -脯氨酸- -二甲基醯胺的方法

Info

Publication number
HK1193612A1
HK1193612A1 HK14106997.4A HK14106997A HK1193612A1 HK 1193612 A1 HK1193612 A1 HK 1193612A1 HK 14106997 A HK14106997 A HK 14106997A HK 1193612 A1 HK1193612 A1 HK 1193612A1
Authority
HK
Hong Kong
Prior art keywords
benzazepin
benzylcarbamoyl
dimethylamide
ylcarbonyl
proline
Prior art date
Application number
HK14106997.4A
Other languages
English (en)
Inventor
Valerie Elizabeth Peal
Original Assignee
Vantia Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vantia Ltd filed Critical Vantia Ltd
Publication of HK1193612A1 publication Critical patent/HK1193612A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK14106997.4A 2011-03-31 2014-07-09 用於製備 -甲基- -四氫- -苯並吖庚因- -基羰基 苄基氨基甲醯基- -脯氨酸- -二甲基醯胺的方法 HK1193612A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161469904P 2011-03-31 2011-03-31
GBGB1105537.3A GB201105537D0 (en) 2011-03-31 2011-03-31 New process
PCT/GB2012/050720 WO2012131389A1 (en) 2011-03-31 2012-03-30 Process for the preparation of 1 - ( 2 -methyl - 4 - ( 2, 3, 4, 5 - tetrahydro - 1 - benzazepin- 1 -ylcarbonyl) benzylcarbamoyl) - l - proline - n, n- dimethylamide

Publications (1)

Publication Number Publication Date
HK1193612A1 true HK1193612A1 (zh) 2014-09-26

Family

ID=44071798

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14106997.4A HK1193612A1 (zh) 2011-03-31 2014-07-09 用於製備 -甲基- -四氫- -苯並吖庚因- -基羰基 苄基氨基甲醯基- -脯氨酸- -二甲基醯胺的方法

Country Status (13)

Country Link
US (1) US9145397B2 (zh)
EP (1) EP2691390B1 (zh)
JP (1) JP5889391B2 (zh)
KR (1) KR101903641B1 (zh)
CN (1) CN103562203B (zh)
BR (1) BR112013024978A2 (zh)
CA (1) CA2867781C (zh)
ES (1) ES2555480T3 (zh)
GB (1) GB201105537D0 (zh)
HK (1) HK1193612A1 (zh)
MX (1) MX2013011151A (zh)
RU (1) RU2594164C2 (zh)
WO (1) WO2012131389A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201105537D0 (en) 2011-03-31 2011-05-18 Vantia Ltd New process
WO2020154581A1 (en) 2019-01-24 2020-07-30 Assia Chemical Industries Ltd Solid state forms of fedovapagon-salicyclic acid co-crystal

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0000079D0 (en) * 2000-01-05 2000-02-23 Ferring Bv Novel antidiuretic agents
GB0015601D0 (en) * 2000-06-26 2000-08-16 Ferring Bv Novel antidiuretic agents
GB0115515D0 (en) * 2001-06-25 2001-08-15 Ferring Bv Oxytocin agonisys
HUP0103064A3 (en) * 2001-07-26 2005-06-28 Egis Gyogyszergyar Nyilvanosan Polymorphic form of 5-chloro-4-(3-{[2-(3,4-dimethoxy-phenyl)-ethyl]-methyl-amino]-propylamino)-3-(2h)-piridazinone fumarate, its use, process for its preparation and pharmaceutical compositions containing it
TWI459947B (zh) 2007-06-26 2014-11-11 Otsuka Pharma Co Ltd 苯并氮呯化合物及藥學製劑
GB201005623D0 (en) * 2010-04-01 2010-05-19 Vantia Ltd New polymorph
GB201105537D0 (en) 2011-03-31 2011-05-18 Vantia Ltd New process

Also Published As

Publication number Publication date
EP2691390B1 (en) 2015-09-16
KR101903641B1 (ko) 2018-10-02
GB201105537D0 (en) 2011-05-18
US9145397B2 (en) 2015-09-29
MX2013011151A (es) 2014-04-16
JP2014509638A (ja) 2014-04-21
KR20140047037A (ko) 2014-04-21
BR112013024978A2 (pt) 2017-02-07
CA2867781C (en) 2019-02-12
CN103562203A (zh) 2014-02-05
ES2555480T3 (es) 2016-01-04
US20140066619A1 (en) 2014-03-06
RU2594164C2 (ru) 2016-08-10
RU2013148584A (ru) 2015-05-10
WO2012131389A1 (en) 2012-10-04
CN103562203B (zh) 2015-01-07
JP5889391B2 (ja) 2016-03-22
EP2691390A1 (en) 2014-02-05
CA2867781A1 (en) 2012-10-04

Similar Documents

Publication Publication Date Title
PL2791093T3 (pl) Sposób wytwarzania 2,3,3,3-tetrafluoropropenu
SG11201405035XA (en) Processes for the preparation of (s)-1-(3-ethoxy-4methoxyphenyl)-2-methanesulfonylethylamine
EP2665696A4 (en) PROCESS FOR THE PREPARATION OF 2,3,3,3-TETRAFLUOR-2-PROPENE
HK1199649A1 (zh) 用於製備聚醯胺的方法
HK1206938A1 (zh) -氯- -三氟-吡啶甲腈的製備方法
IL233937A0 (en) Process for the preparation of 3-difluoromethyl-1-methyl-1h-pyrazole-4-carboxylic-n-methoxy-[1-methyl-2-phenylethyl]amide
SG11201400939YA (en) Process for the preparation of methoxymelonal
HK1198584A1 (zh) 曲伏前列素的製備方法
HK1213262A1 (zh) 二氧戊環- -基甲基 -吡唑- -胺的製備方法
EP2885302A4 (en) PROCESS FOR THE PREPARATION OF DIPEPTIDYLPEPTIDASE INHIBITORS
HK1193612A1 (zh) 用於製備 -甲基- -四氫- -苯並吖庚因- -基羰基 苄基氨基甲醯基- -脯氨酸- -二甲基醯胺的方法
SG11201400090UA (en) Process for the preparation of olefins
HK1214825A1 (zh) 用於製備 -氰基- 吡啶- -基 乙基 -甲基硫亞胺的改善方法
GB201119690D0 (en) Process for the preparation of compounds
PL393916A1 (pl) Sposób wytwarzania związków karbapenamowych
IL229669A0 (en) Process for the preparation of 1,2,3 triazole 4 carboxamide
SG11201400091XA (en) Process for the preparation of olefins
PL399603A1 (pl) Sposób wytwarzania 3β,15α-dihydroksy-5α-androst-17-onu
PL392489A1 (pl) Sposób wytwarzania 3ß,7α-dihydroksy-5α-androst-17-onu
PL390553A1 (pl) Sposób otrzymywania 1,2-epoksybutan-3-olu
PL390554A1 (pl) Sposób otrzymywania 2,3-epoksybutan-1-olu
HUP1100291A2 (en) Process for the preparation of prostaglandin amides
PL394420A1 (pl) Sposób wytwarzania dilauroilofluoresceiny
PL394378A1 (pl) Sposób otrzymywania E-2-amino-4-nitrostilbenów

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20200328